Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo
Identifieur interne :
001727 ( PascalFrancis/Curation );
précédent :
001726;
suivant :
001728
Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo
Auteurs : A. Boireau [
France] ;
J.-M. Miquet ;
P. Dubedat ;
M. Meunier ;
A. DobleSource :
-
Neuroreport : (Oxford) [ 0959-4965 ] ; 1994.
RBID : Pascal:95-0040742
Descripteurs français
- Pascal (Inist)
- Parkinson maladie,
Pathologie expérimentale,
Corps strié,
Neurotoxine,
Dopamine,
Libération,
Riluzole,
Antagoniste,
Récepteur glutamate,
Animal,
Rat.
English descriptors
| pA |
| A01 | 01 | 1 | | @0 0959-4965 |
|---|
| A03 | | 1 | | @0 Neuroreport : (Oxf.) |
|---|
| A05 | | | | @2 5 |
|---|
| A06 | | | | @2 16 |
|---|
| A08 | 01 | 1 | ENG | @1 Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo |
|---|
| A11 | 01 | 1 | | @1 BOIREAU (A.) |
|---|
| A11 | 02 | 1 | | @1 MIQUET (J.-M.) |
|---|
| A11 | 03 | 1 | | @1 DUBEDAT (P.) |
|---|
| A11 | 04 | 1 | | @1 MEUNIER (M.) |
|---|
| A11 | 05 | 1 | | @1 DOBLE (A.) |
|---|
| A14 | 01 | | | @1 Rhône-Poulenc Rorer S.A., cent. rech. Vitry-Alfortville, dép. biologie @2 94403 Vitry-sur-Seine @3 FRA |
|---|
| A20 | | | | @1 2157-2160 |
|---|
| A21 | | | | @1 1994 |
|---|
| A23 | 01 | | | @0 ENG |
|---|
| A43 | 01 | | | @1 INIST @2 22534 @5 354000042106710390 |
|---|
| A44 | | | | @0 0000 |
|---|
| A45 | | | | @0 23 ref. |
|---|
| A47 | 01 | 1 | | @0 95-0040742 |
|---|
| A60 | | | | @1 P |
|---|
| A61 | | | | @0 A |
|---|
| A64 | 01 | 1 | | @0 Neuroreport : (Oxford) |
|---|
| A66 | 01 | | | @0 GBR |
|---|
| C02 | 01 | X | | @0 002B02B11 |
|---|
| C03 | 01 | X | FRE | @0 Parkinson maladie @2 NM @5 01 |
|---|
| C03 | 01 | X | ENG | @0 Parkinson disease @2 NM @5 01 |
|---|
| C03 | 01 | X | SPA | @0 Parkinson enfermedad @2 NM @5 01 |
|---|
| C03 | 02 | X | FRE | @0 Pathologie expérimentale @5 02 |
|---|
| C03 | 02 | X | ENG | @0 Experimental disease @5 02 |
|---|
| C03 | 02 | X | SPA | @0 Patología experimental @5 02 |
|---|
| C03 | 03 | X | FRE | @0 Corps strié @5 03 |
|---|
| C03 | 03 | X | ENG | @0 Corpus striatum @5 03 |
|---|
| C03 | 03 | X | SPA | @0 Cuerpo estriado @5 03 |
|---|
| C03 | 04 | X | FRE | @0 Neurotoxine @5 04 |
|---|
| C03 | 04 | X | ENG | @0 Neurotoxin @5 04 |
|---|
| C03 | 04 | X | SPA | @0 Neurotoxina @5 04 |
|---|
| C03 | 05 | X | FRE | @0 Dopamine @2 NK @2 FR @5 05 |
|---|
| C03 | 05 | X | ENG | @0 Dopamine @2 NK @2 FR @5 05 |
|---|
| C03 | 05 | X | SPA | @0 Dopamina @2 NK @2 FR @5 05 |
|---|
| C03 | 06 | X | FRE | @0 Libération @5 06 |
|---|
| C03 | 06 | X | ENG | @0 Release @5 06 |
|---|
| C03 | 06 | X | SPA | @0 Liberación @5 06 |
|---|
| C03 | 07 | X | FRE | @0 Riluzole @2 NK @2 FR @5 10 |
|---|
| C03 | 08 | X | FRE | @0 Antagoniste @5 11 |
|---|
| C03 | 08 | X | ENG | @0 Antagonist @5 11 |
|---|
| C03 | 08 | X | SPA | @0 Antagonista @5 11 |
|---|
| C03 | 09 | X | FRE | @0 Récepteur glutamate @5 12 |
|---|
| C03 | 09 | X | ENG | @0 Glutamate receptor @5 12 |
|---|
| C03 | 09 | X | SPA | @0 Receptor glutámato @5 12 |
|---|
| C03 | 10 | X | FRE | @0 Animal @5 14 |
|---|
| C03 | 10 | X | ENG | @0 Animal @5 14 |
|---|
| C03 | 10 | X | SPA | @0 Animal @5 14 |
|---|
| C03 | 11 | X | FRE | @0 Rat @5 41 |
|---|
| C03 | 11 | X | ENG | @0 Rat @5 41 |
|---|
| C03 | 11 | X | SPA | @0 Rata @5 41 |
|---|
| C07 | 01 | X | FRE | @0 Maladie dégénérative @5 17 |
|---|
| C07 | 01 | X | ENG | @0 Degenerative disease @5 17 |
|---|
| C07 | 01 | X | SPA | @0 Enfermedad degenerativa @5 17 |
|---|
| C07 | 02 | X | FRE | @0 Système nerveux pathologie @5 18 |
|---|
| C07 | 02 | X | ENG | @0 Nervous system diseases @5 18 |
|---|
| C07 | 02 | X | SPA | @0 Sistema nervioso patología @5 18 |
|---|
| C07 | 03 | X | FRE | @0 Noyau gris central @5 23 |
|---|
| C07 | 03 | X | ENG | @0 Basal ganglion @5 23 |
|---|
| C07 | 03 | X | SPA | @0 Núcleo basal @5 23 |
|---|
| C07 | 04 | X | FRE | @0 Encéphale @5 24 |
|---|
| C07 | 04 | X | ENG | @0 Brain (vertebrata) @5 24 |
|---|
| C07 | 04 | X | SPA | @0 Encéfalo @5 24 |
|---|
| C07 | 05 | X | FRE | @0 Système nerveux central @5 25 |
|---|
| C07 | 05 | X | ENG | @0 Central nervous system @5 25 |
|---|
| C07 | 05 | X | SPA | @0 Sistema nervioso central @5 25 |
|---|
| C07 | 06 | X | FRE | @0 Neurotransmetteur @5 29 |
|---|
| C07 | 06 | X | ENG | @0 Neurotransmitter @5 29 |
|---|
| C07 | 06 | X | SPA | @0 Neurotransmisor @5 29 |
|---|
| C07 | 07 | X | FRE | @0 Catécholamine @5 30 |
|---|
| C07 | 07 | X | ENG | @0 Catecholamine @5 30 |
|---|
| C07 | 07 | X | SPA | @0 Catecolamina @5 30 |
|---|
| C07 | 08 | X | FRE | @0 Rodentia @2 NS |
|---|
| C07 | 08 | X | ENG | @0 Rodentia @2 NS |
|---|
| C07 | 08 | X | SPA | @0 Rodentia @2 NS |
|---|
| C07 | 09 | X | FRE | @0 Mammalia @2 NS |
|---|
| C07 | 09 | X | ENG | @0 Mammalia @2 NS |
|---|
| C07 | 09 | X | SPA | @0 Mammalia @2 NS |
|---|
| C07 | 10 | X | FRE | @0 Vertebrata @2 NS |
|---|
| C07 | 10 | X | ENG | @0 Vertebrata @2 NS |
|---|
| C07 | 10 | X | SPA | @0 Vertebrata @2 NS |
|---|
| N21 | | | | @1 039 |
|---|
|
|---|
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001920
Links to Exploration step
Pascal:95-0040742
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Riluzole and experimental parkinsonism : partial antagonism of MPP<sup>+</sup>
-induced increase in striatal extracellular dopamine in rats in vivo</title><author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S.A., cent. rech. Vitry-Alfortville, dép. biologie</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J.-M." last="Miquet">J.-M. Miquet</name>
</author><author><name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P." last="Dubedat">P. Dubedat</name>
</author><author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
</author><author><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A." last="Doble">A. Doble</name>
</author><publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">95-0040742</idno>
<date when="1994">1994</date>
<idno type="stanalyst">PASCAL 95-0040742 INIST</idno>
<idno type="RBID">Pascal:95-0040742</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001920</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001727</idno>
</publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Riluzole and experimental parkinsonism : partial antagonism of MPP<sup>+</sup>
-induced increase in striatal extracellular dopamine in rats in vivo</title><author><name sortKey="Boireau, A" sort="Boireau, A" uniqKey="Boireau A" first="A." last="Boireau">A. Boireau</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Rhône-Poulenc Rorer S.A., cent. rech. Vitry-Alfortville, dép. biologie</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
</inist:fA14><country>France</country>
</affiliation><author><name sortKey="Miquet, J M" sort="Miquet, J M" uniqKey="Miquet J" first="J.-M." last="Miquet">J.-M. Miquet</name>
</author><author><name sortKey="Dubedat, P" sort="Dubedat, P" uniqKey="Dubedat P" first="P." last="Dubedat">P. Dubedat</name>
</author><author><name sortKey="Meunier, M" sort="Meunier, M" uniqKey="Meunier M" first="M." last="Meunier">M. Meunier</name>
</author><author><name sortKey="Doble, A" sort="Doble, A" uniqKey="Doble A" first="A." last="Doble">A. Doble</name>
</author><series><title level="j" type="main">Neuroreport : (Oxford)</title>
<title level="j" type="abbreviated">Neuroreport : (Oxf.)</title>
<idno type="ISSN">0959-4965</idno>
<imprint><date when="1994">1994</date>
</imprint><seriesStmt><title level="j" type="main">Neuroreport : (Oxford)</title>
<title level="j" type="abbreviated">Neuroreport : (Oxf.)</title>
<idno type="ISSN">0959-4965</idno>
</seriesStmt><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animal</term>
<term>Antagonist</term>
<term>Corpus striatum</term>
<term>Dopamine</term>
<term>Experimental disease</term>
<term>Glutamate receptor</term>
<term>Neurotoxin</term>
<term>Parkinson disease</term>
<term>Rat</term>
<term>Release</term>
</keywords><keywords scheme="Pascal" xml:lang="fr"><term>Parkinson maladie</term>
<term>Pathologie expérimentale</term>
<term>Corps strié</term>
<term>Neurotoxine</term>
<term>Dopamine</term>
<term>Libération</term>
<term>Riluzole</term>
<term>Antagoniste</term>
<term>Récepteur glutamate</term>
<term>Animal</term>
<term>Rat</term>
</keywords><inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0959-4965</s0>
</fA01><fA03 i2="1"><s0>Neuroreport : (Oxf.)</s0>
</fA03><fA08 i1="01" i2="1" l="ENG"><s1>Riluzole and experimental parkinsonism : partial antagonism of MPP<sup>+</sup>
-induced increase in striatal extracellular dopamine in rats in vivo</s1><fA11 i1="01" i2="1"><s1>BOIREAU (A.)</s1>
</fA11><fA11 i1="02" i2="1"><s1>MIQUET (J.-M.)</s1>
</fA11><fA11 i1="03" i2="1"><s1>DUBEDAT (P.)</s1>
</fA11><fA11 i1="04" i2="1"><s1>MEUNIER (M.)</s1>
</fA11><fA11 i1="05" i2="1"><s1>DOBLE (A.)</s1>
</fA11><fA14 i1="01"><s1>Rhône-Poulenc Rorer S.A., cent. rech. Vitry-Alfortville, dép. biologie</s1>
<s2>94403 Vitry-sur-Seine</s2>
<s3>FRA</s3>
</fA14><fA20><s1>2157-2160</s1>
</fA20><fA21><s1>1994</s1>
</fA21><fA23 i1="01"><s0>ENG</s0>
</fA23><fA43 i1="01"><s1>INIST</s1>
<s2>22534</s2>
<s5>354000042106710390</s5>
</fA43><fA44><s0>0000</s0>
</fA44><fA45><s0>23 ref.</s0>
</fA45><fA47 i1="01" i2="1"><s0>95-0040742</s0>
</fA47><fA64 i1="01" i2="1"><s0>Neuroreport : (Oxford)</s0>
</fA64><fA66 i1="01"><s0>GBR</s0>
</fA66><fC02 i1="01" i2="X"><s0>002B02B11</s0>
</fC02><fC03 i1="01" i2="X" l="FRE"><s0>Parkinson maladie</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="ENG"><s0>Parkinson disease</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="01" i2="X" l="SPA"><s0>Parkinson enfermedad</s0>
<s2>NM</s2>
<s5>01</s5>
</fC03><fC03 i1="02" i2="X" l="FRE"><s0>Pathologie expérimentale</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="ENG"><s0>Experimental disease</s0>
<s5>02</s5>
</fC03><fC03 i1="02" i2="X" l="SPA"><s0>Patología experimental</s0>
<s5>02</s5>
</fC03><fC03 i1="03" i2="X" l="FRE"><s0>Corps strié</s0>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="ENG"><s0>Corpus striatum</s0>
<s5>03</s5>
</fC03><fC03 i1="03" i2="X" l="SPA"><s0>Cuerpo estriado</s0>
<s5>03</s5>
</fC03><fC03 i1="04" i2="X" l="FRE"><s0>Neurotoxine</s0>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="ENG"><s0>Neurotoxin</s0>
<s5>04</s5>
</fC03><fC03 i1="04" i2="X" l="SPA"><s0>Neurotoxina</s0>
<s5>04</s5>
</fC03><fC03 i1="05" i2="X" l="FRE"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="ENG"><s0>Dopamine</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03><fC03 i1="05" i2="X" l="SPA"><s0>Dopamina</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>05</s5>
</fC03><fC03 i1="06" i2="X" l="FRE"><s0>Libération</s0>
<s5>06</s5>
</fC03><fC03 i1="06" i2="X" l="ENG"><s0>Release</s0>
<s5>06</s5>
</fC03><fC03 i1="06" i2="X" l="SPA"><s0>Liberación</s0>
<s5>06</s5>
</fC03><fC03 i1="07" i2="X" l="FRE"><s0>Riluzole</s0>
<s2>NK</s2>
<s2>FR</s2>
<s5>10</s5>
</fC03><fC03 i1="08" i2="X" l="FRE"><s0>Antagoniste</s0>
<s5>11</s5>
</fC03><fC03 i1="08" i2="X" l="ENG"><s0>Antagonist</s0>
<s5>11</s5>
</fC03><fC03 i1="08" i2="X" l="SPA"><s0>Antagonista</s0>
<s5>11</s5>
</fC03><fC03 i1="09" i2="X" l="FRE"><s0>Récepteur glutamate</s0>
<s5>12</s5>
</fC03><fC03 i1="09" i2="X" l="ENG"><s0>Glutamate receptor</s0>
<s5>12</s5>
</fC03><fC03 i1="09" i2="X" l="SPA"><s0>Receptor glutámato</s0>
<s5>12</s5>
</fC03><fC03 i1="10" i2="X" l="FRE"><s0>Animal</s0>
<s5>14</s5>
</fC03><fC03 i1="10" i2="X" l="ENG"><s0>Animal</s0>
<s5>14</s5>
</fC03><fC03 i1="10" i2="X" l="SPA"><s0>Animal</s0>
<s5>14</s5>
</fC03><fC03 i1="11" i2="X" l="FRE"><s0>Rat</s0>
<s5>41</s5>
</fC03><fC03 i1="11" i2="X" l="ENG"><s0>Rat</s0>
<s5>41</s5>
</fC03><fC03 i1="11" i2="X" l="SPA"><s0>Rata</s0>
<s5>41</s5>
</fC03><fC07 i1="01" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>17</s5>
</fC07><fC07 i1="01" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>17</s5>
</fC07><fC07 i1="01" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>17</s5>
</fC07><fC07 i1="02" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>18</s5>
</fC07><fC07 i1="02" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>18</s5>
</fC07><fC07 i1="02" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>18</s5>
</fC07><fC07 i1="03" i2="X" l="FRE"><s0>Noyau gris central</s0>
<s5>23</s5>
</fC07><fC07 i1="03" i2="X" l="ENG"><s0>Basal ganglion</s0>
<s5>23</s5>
</fC07><fC07 i1="03" i2="X" l="SPA"><s0>Núcleo basal</s0>
<s5>23</s5>
</fC07><fC07 i1="04" i2="X" l="FRE"><s0>Encéphale</s0>
<s5>24</s5>
</fC07><fC07 i1="04" i2="X" l="ENG"><s0>Brain (vertebrata)</s0>
<s5>24</s5>
</fC07><fC07 i1="04" i2="X" l="SPA"><s0>Encéfalo</s0>
<s5>24</s5>
</fC07><fC07 i1="05" i2="X" l="FRE"><s0>Système nerveux central</s0>
<s5>25</s5>
</fC07><fC07 i1="05" i2="X" l="ENG"><s0>Central nervous system</s0>
<s5>25</s5>
</fC07><fC07 i1="05" i2="X" l="SPA"><s0>Sistema nervioso central</s0>
<s5>25</s5>
</fC07><fC07 i1="06" i2="X" l="FRE"><s0>Neurotransmetteur</s0>
<s5>29</s5>
</fC07><fC07 i1="06" i2="X" l="ENG"><s0>Neurotransmitter</s0>
<s5>29</s5>
</fC07><fC07 i1="06" i2="X" l="SPA"><s0>Neurotransmisor</s0>
<s5>29</s5>
</fC07><fC07 i1="07" i2="X" l="FRE"><s0>Catécholamine</s0>
<s5>30</s5>
</fC07><fC07 i1="07" i2="X" l="ENG"><s0>Catecholamine</s0>
<s5>30</s5>
</fC07><fC07 i1="07" i2="X" l="SPA"><s0>Catecolamina</s0>
<s5>30</s5>
</fC07><fC07 i1="08" i2="X" l="FRE"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07><fC07 i1="08" i2="X" l="ENG"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07><fC07 i1="08" i2="X" l="SPA"><s0>Rodentia</s0>
<s2>NS</s2>
</fC07><fC07 i1="09" i2="X" l="FRE"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07><fC07 i1="09" i2="X" l="ENG"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07><fC07 i1="09" i2="X" l="SPA"><s0>Mammalia</s0>
<s2>NS</s2>
</fC07><fC07 i1="10" i2="X" l="FRE"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07><fC07 i1="10" i2="X" l="ENG"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07><fC07 i1="10" i2="X" l="SPA"><s0>Vertebrata</s0>
<s2>NS</s2>
</fC07><fN21><s1>039</s1>
</fN21>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001727 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001727 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= PascalFrancis
|étape= Curation
|type= RBID
|clé= Pascal:95-0040742
|texte= Riluzole and experimental parkinsonism : partial antagonism of MPP+-induced increase in striatal extracellular dopamine in rats in vivo
}}
| This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 |  |
